DLD Asset Management’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

DLD Asset Management’s Portfolio NVET Stock Details NVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-26,000	Closed	-$174K	–	128
2017 Q2	$174K	Buy	+26,000	New	+$164K	0.02%	85

DLD Asset Management's NVET Position: Q3 2017 in Review

DLD Asset Management sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q3 2017, closing a stake of 26,000 shares — an estimated $174K sold.

DLD Asset Management first reported a position in NVET in Q2 2017 and held it in 1 quarter. The position peaked at $174K in Q2 2017. 0 funds tracked by Wall St. Rank hold NVET as of Q3 2017.

DLD Asset Management reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q3 2017 after selling out during the quarter.
DLD Asset Management sold 26,000 Nexvet Biopharma plc Ordinary Shares shares in Q3 2017, an estimated $174K.
DLD Asset Management first reported a position in Nexvet Biopharma plc Ordinary Shares in Q2 2017 and held it in 1 quarter.
DLD Asset Management's Nexvet Biopharma plc Ordinary Shares position peaked at $174K in Q2 2017.
0 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q3 2017.

Based on DLD Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.